Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1979 1
1980 1
1982 1
1983 1
1984 1
1985 1
1986 1
1987 2
1988 2
1989 5
1990 8
1991 2
1992 3
1993 8
1994 3
1995 3
1996 1
1997 4
1998 11
1999 4
2000 5
2001 9
2002 10
2003 18
2004 18
2005 14
2006 18
2007 36
2008 42
2009 43
2010 60
2011 63
2012 77
2013 91
2014 89
2015 112
2016 131
2017 155
2018 188
2019 175
2020 212
2021 273
2022 328
2023 297
2024 338
2025 333
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,875 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors.
Luo Y, Xia Y, Liu D, Li X, Li H, Liu J, Zhou D, Dong Y, Li X, Qian Y, Xu C, Tao K, Li G, Pan W, Zhong Q, Liu X, Xu S, Wang Z, Liu R, Zhang W, Shan W, Fang T, Wang S, Peng Z, Jin P, Jin N, Shi S, Chen Y, Wang M, Jiao X, Luo M, Gong W, Wang Y, Yao Y, Zhao Y, Huang X, Ji X, He Z, Zhao G, Liu R, Wu M, Chen G, Hong L; COCPO Consortium; Ma D, Fang Y, Liang H, Gao Q. Luo Y, et al. Among authors: jin p. Cell. 2024 Sep 5;187(18):4905-4925.e24. doi: 10.1016/j.cell.2024.06.013. Epub 2024 Jul 5. Cell. 2024. PMID: 38971151 Free article. Clinical Trial.
Inhibitors and PROTACs of CDK2: challenges and opportunities.
Zeng Y, Ren X, Jin P, Fan Z, Liu M, Zhang Y, Li L, Zhuo M, Wang J, Li Z, Wu M. Zeng Y, et al. Among authors: jin p. Expert Opin Drug Discov. 2024 Sep;19(9):1125-1148. doi: 10.1080/17460441.2024.2376655. Epub 2024 Jul 12. Expert Opin Drug Discov. 2024. PMID: 38994606 Review.
Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on FMR1 Premutation.
Tassone F, Protic D, Allen EG, Archibald AD, Baud A, Brown TW, Budimirovic DB, Cohen J, Dufour B, Eiges R, Elvassore N, Gabis LV, Grudzien SJ, Hall DA, Hessl D, Hogan A, Hunter JE, Jin P, Jiraanont P, Klusek J, Kooy RF, Kraan CM, Laterza C, Lee A, Lipworth K, Losh M, Loesch D, Lozano R, Mailick MR, Manolopoulos A, Martinez-Cerdeno V, McLennan Y, Miller RM, Montanaro FAM, Mosconi MW, Potter SN, Raspa M, Rivera SM, Shelly K, Todd PK, Tutak K, Wang JY, Wheeler A, Winarni TI, Zafarullah M, Hagerman RJ. Tassone F, et al. Among authors: jin p. Cells. 2023 Sep 21;12(18):2330. doi: 10.3390/cells12182330. Cells. 2023. PMID: 37759552 Free PMC article. Review.
Characterization and visualization of tandem repeats at genome scale.
Dolzhenko E, English A, Dashnow H, De Sena Brandine G, Mokveld T, Rowell WJ, Karniski C, Kronenberg Z, Danzi MC, Cheung WA, Bi C, Farrow E, Wenger A, Chua KP, Martínez-Cerdeño V, Bartley TD, Jin P, Nelson DL, Zuchner S, Pastinen T, Quinlan AR, Sedlazeck FJ, Eberle MA. Dolzhenko E, et al. Among authors: jin p. Nat Biotechnol. 2024 Oct;42(10):1606-1614. doi: 10.1038/s41587-023-02057-3. Epub 2024 Jan 2. Nat Biotechnol. 2024. PMID: 38168995 Free PMC article.
Deep learning-enabled pelvic ultrasound images for accurate diagnosis of ovarian cancer in China: a retrospective, multicentre, diagnostic study.
Gao Y, Zeng S, Xu X, Li H, Yao S, Song K, Li X, Chen L, Tang J, Xing H, Yu Z, Zhang Q, Zeng S, Yi C, Xie H, Xiong X, Cai G, Wang Z, Wu Y, Chi J, Jiao X, Qin Y, Mao X, Chen Y, Jin X, Mo Q, Chen P, Huang Y, Shi Y, Wang J, Zhou Y, Ding S, Zhu S, Liu X, Dong X, Cheng L, Zhu L, Cheng H, Cha L, Hao Y, Jin C, Zhang L, Zhou P, Sun M, Xu Q, Chen K, Gao Z, Zhang X, Ma Y, Liu Y, Xiao L, Xu L, Peng L, Hao Z, Yang M, Wang Y, Ou H, Jia Y, Tian L, Zhang W, Jin P, Tian X, Huang L, Wang Z, Liu J, Fang T, Yan D, Cao H, Ma J, Li X, Zheng X, Lou H, Song C, Li R, Wang S, Li W, Zheng X, Chen J, Li G, Chen R, Xu C, Yu R, Wang J, Xu S, Kong B, Xie X, Ma D, Gao Q. Gao Y, et al. Among authors: jin p. Lancet Digit Health. 2022 Mar;4(3):e179-e187. doi: 10.1016/S2589-7500(21)00278-8. Lancet Digit Health. 2022. PMID: 35216752 Free article.
Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial.
Liu X, Dai Q, Ye R, Zi W, Liu Y, Wang H, Zhu W, Ma M, Yin Q, Li M, Fan X, Sun W, Han Y, Lv Q, Liu R, Yang D, Shi Z, Zheng D, Deng X, Wan Y, Wang Z, Geng Y, Chen X, Zhou Z, Liao G, Jin P, Liu Y, Liu X, Zhang M, Zhou F, Shi H, Zhang Y, Guo F, Yin C, Niu G, Zhang M, Cai X, Zhu Q, Chen Z, Liang Y, Li B, Lin M, Wang W, Xu H, Fu X, Liu W, Tian X, Gong Z, Shi H, Wang C, Lv P, Tao Z, Zhu L, Yang S, Hu W, Jiang P, Liebeskind DS, Pereira VM, Leung T, Yan B, Davis S, Xu G, Nogueira RG; BEST Trial Investigators. Liu X, et al. Among authors: jin p. Lancet Neurol. 2020 Feb;19(2):115-122. doi: 10.1016/S1474-4422(19)30395-3. Epub 2019 Dec 9. Lancet Neurol. 2020. PMID: 31831388 Clinical Trial.
2,875 results